1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Asthma Treatment Drugs Industry Forecasts - China Focus

Asthma Treatment Drugs Industry Forecasts - China Focus

  • March 2016
  • -
  • Asia Market Information & Development Company
  • -
  • 56 pages

This study focuses on China’s Asthma Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market for the consumptions of goods and services. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. Rapid consolidation between medium and large players is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to improve competitiveness in the world market.

Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector’s economies of scale have yet to be achieved. Most domestic manufacturers lack the autonomic intellectual property and financial resources to develop their own brand name products.

This new study focuses on industry trends and forecasts with historical data (2005, 2010 and 2015) and long-term forecasts through 2020 and 2025 are presented.
The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and our in-house databases.

Asia Market Info & Dev Co. is one of the leading sources for up-to-date market information and research on the fastest-growing Chinese markets. We have published over 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our publications are intended to help international marketers identify business opportunities and promote their product sales in the Chinese markets.

Table Of Contents

Asthma Treatment Drugs Industry Forecasts - China Focus
TABLE OF CONTENTS



I. INTRODUCTION

Report Scope and Methodology
Executive Summary

II. ASTHMA TREATMENT DRUGS OUTPUT AND DEMAND

Overview
Asthma Treatment Drugs Classification, Demand, Output and Share
Asthma Treatment Drugs Output and Demand
Glucocorticoid Drugs
?2 Receptor Agonists
Leukotriene Receptor Antagonist
Anticholinergic Drugs
Theophylline
Antiallergic Agent
Other Asthma Treatment Drugs
Asthma Treatment Drugs Imports and Exports
Asthma Treatment Drugs Imports
Asthma Treatment Drugs Exports



LIST OF TABLES



I. INTRODUCTION

Economic Outlook Summary
Asthma Treatment Drugs Supply and Demand Summary

II. ASTHMA TREATMENT DRUGS OUTPUT AND DEMAND

Asthma Treatment Drugs Output and Demand
Asthma Treatment Drugs Classification, Output, Demand and Share
Glucocorticoid Drugs Capacity, Output, Import, Export and Demand
?2 Receptor Agonists Capacity, Output, Import, Export and Demand
Leukotriene Receptor Antagonist Capacity, Output, Import, Export and Demand
Anticholinergic Drugs Capacity, Output, Import, Export and Demand
Theophylline Drugs Capacity, Output, Import, Export and Demand
Antiallergic Agent Capacity, Output, Import, Export and Demand
Other Asthma Treatment Drugs Capacity, Output, Import, Export and Demand
China Asthma Treatment Drugs Imports and Exports



LIST OF CHARTS



I. INTRODUCTION

Asthma Treatment Drugs Capacity, Output, Demand

II. ASTHMA TREATMENT DRUGS OUTPUT AND DEMAND

Total Asthma Treatment Drugs Output and Demand
Asthma Treatment Drugs Classification and Output Share
Asthma Treatment Drugs Classification and Demand Share
Glucocorticoid Drugs Output
Glucocorticoid Drugs Demand
?2 Receptor Agonists Output
?2 Receptor Agonists Demand
Leukotriene Receptor Antagonist Output
Leukotriene Receptor Antagonist Demand
Anticholinergic Drugs Output
Anticholinergic Drugs Demand
Theophylline Output
Theophylline Demand
Antiallergic Agent Output
Antiallergic Agent Demand
Total Asthma Treatment Drugs Imports
Total Asthma Treatment Drugs Exports

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

  • $ 10995
  • Industry report
  • October 2016
  • by Global Data

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. It is characterized ...

Colorectal Cancer KOL Insight 2016

Colorectal Cancer KOL Insight 2016

  • $ 8085
  • Industry report
  • October 2016
  • by Firstword Pharma

KOLs embrace novel MoAs as low survival rates drive search for new treatments Faced with persistently low survival rates, KOLs are calling for new approaches to treat late-stage colorectal cancer (CRC). ...

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations

  • $ 6995
  • Industry report
  • December 2016
  • by GBI Research

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations Summary Hepatitis C is a blood-borne viral infection ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.